Piyasa kapalı· · USD · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
Temettüler dahil toplam getiri.
LeMaitre Vascular (LMAT) is drawing fresh attention after its shares closed at US$80.58, with recent returns showing modest gains over the past month and a decline over the past 3 months. Viewed over a longer stretch, LeMaitre Vascular’s 1 year total shareholder return is down 7.29%, even as the 3 year total shareholder return of 54.81% and 5 year total shareholder return of 56.88% point to earlier strength that has cooled with the recent 90 day share price pullback of 14.21% from current...
LeMaitre Vascular has delivered a 56.9% share price gain over the past five years, yet its recent flat patch raises a simple question for you as an investor. Are the cash flows from this medical device business strong and reliable enough to support where the stock trades today? That 56.9% move over five years puts real weight on whether LeMaitre Vascular's cash generation can support the value the market now assigns to the business. The company focuses on vascular devices that can support...
Fiyatın 50 ve 200 günlük hareketli ortalamalara göre konumu.
Makkler Adil Değer, finansal sağlık skoru, analist görüşü, benzer şirketler ve MakklerAI.
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
Üçüncü taraf yayıncıların bu şirket hakkındaki son başlıkları; Makkler'in kendi editoryal içeriğinden ayrı tutulur ve dış kaynağa yönlendirir. Başlıkların doğruluğu ilgili yayıncının sorumluluğundadır.